Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Telo Genomics Corp V.TELO

Alternate Symbol(s):  TDSGF

Telo Genomics Corp. is a biotech company pioneering the telomere platform in the industry with applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. The Company's lead application, TELO-MM is being developed to provide actionable information to medical professionals in the treatment of multiple myeloma, a form of blood cancer. Its clinical studies and product development design includes TeloView SMM, TeloView Test to Predict Patient Resistance to Treatment, development in collaboration with the Mayo Clinic and TeloView Test to monitor minimal residual disease in MM patients. The Company, by combining quantitative analysis of three-dimensional telomeres with molecular biology and artificial intelligence to recognize disease associated genetic instability, is developing products that improve day-to-day care for patients by serving the needs of pathologists, clinicians, academic researchers and drug developers.


TSXV:TELO - Post by User

Bullboard Posts
Comment by STOCKMAN70on Oct 09, 2017 6:23pm
124 Views
Post# 26792748

RE:Doubling DXD position

RE:Doubling DXD positionTailwinds, you have some respectable stocks in your current portfolio and congratualtions on Patriot One.  I feel like your stats are unfairly represented on the hgh side though - the 4 stocks in the portfolio where you averaged down should weighted with a 2x multiple since you made secondary purchases.  Doing this would give you an average of 15.9% instead of 25.2%.  This is based on an assumption that you purchased an equivalent $ amount on all your positionos on the intial buy.  

The way it is now you can cut the loss in half of any stock in the portfolio by making a second buy which manipulates the return.

Just an observation.

glta
Bullboard Posts